Loxo Oncology Announces Global Development and Commercialization Partnership with Bayer for Larotrectinib and LOXO-195

Article Related Articles (1) Stock Quotes (1)

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX

6. GOOGL
7. APGE
8. MU
9. HOOD
10. ABBV

Top News Most Read Special Reports

Go back to Loxo Oncology Announces Global Development and Commercialization Partnership with Bayer for Larotrectinib and LOXO-195

Loxo Oncology (LOXO) to Resume Trading at 7:30 AM ET

November 14, 2017 7:20 AM EST

Loxo Oncology (NASDAQ: LOXO) to Resume Trading at 7:30 AM ET

... More